Health
Ultragenyx Drug Trial Fails
Ultragenyx's experimental therapy for Angelman syndrome failed in a late-stage trial, showing no benefit compared to a sham treatment.
Coverage timeline — 1 article
STAT News
Ultragenyx said its experimental therapy for Angelman syndrome, a rare disease, showed no benefit compared to a sham treatment in a Phase 3 trial.
2026-09-02 20:37 UTC